Most Recent
South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson's Janssen Biotech to invalidate two patents for Crohn's disease drug Stelara, after reaching a licencing agreement over the medicine in the US.
A judge has rejected McDonald's claim that Hungry Jack's Big Jack burger infringed its Big Mac trade mark, but found that Hungry Jack's misled consumers by boasting that its burger had 25 per cent more beef.
Novartis unit Sandoz AG has lost its bid to revoke Bayer’s patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giant’s patents were valid.
German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.
A solar cell patent at the heart of intellectual property litigation brought by South Korean technology giant Hanwha has been found invalid.
A judge has upheld findings from IP Australia that South Korean biotech ToolGen's genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.
Novartis unit Sandoz has won its bid to stay a case by rival Lundbeck, including orders for damages previously calculated at $26.3 million and counting, despite having succeeded at the High Court in a dispute over its patent for blockbuster antidepressant Lexapro.
Apple can argue an Australian non-practicing entity that claims its patents for a remote entry system were infringed by the tech company's Touch ID and Face ID technology are invalid because of a Hewlett Packard handheld device that was first sold in 2000.
US singer Katy Perry and an Australian fashion designer are at loggerheads over court orders to be made following a judge's finding the pop star was liable for trade mark infringement, with concerns raised that Perry's 'Teenage Dream' shorts could "fall between the cracks".
An infringement ruling against US singer Katy Perry in a case brought by an Australian fashion designer is a "win for the little guy", experts say, showing that fame doesn't give celebrities a blank cheque to exploit their brand at the expense of someone's else's registered trade mark.